Abstract:OBJECTIVES:Human gingiva-derived mesenchymal stem cells (GMSCs) have emerged as a new MSC population exhibiting robust immune regulatory functions, multipotent differentiation potential, and regenerative ability. However, the effects of GMSCs on T cells remain unexplored. Herein, we aimed to evaluate whether GMSCs promote osteogenic differentiation by regulating immune cells. METHODS:The GMSC phenotype was confirmed using the colony-forming assay, immunophenotyping, Oil red O staining, and Alizarin red staining. mRNA expression levels of proinflammatory molecules (interleukin-1β [IL-1β] and tumor necrosis factor-α [TNF-α]) and anti-inflammatory factors (IL-10) were measured by quantitative reverse-transcription PCR (qRT-PCR). Then, MC3T3-E1 cells were treated with the collected co-culture supernatant, followed by alkaline phosphatase (ALP) and immunofluorescence staining to evaluate osteogenic differentiation of MC3T3-E1 cells. qRT-PCR and western blotting were employed to analyze the expression levels of osteogenic differentiation proteins, including collagen type I (COL-1), ALP, osteopontin (OPN), and runt-related transcription factor 2 (RUNX2). RESULTS:GMSCs were successfully isolated and identified. We observed that GMSCs suppressed the activated T-cell function by downregulating IL-1β and TNF-α and upregulating IL-10. Simultaneously, the expression levels of osteogenesis-related genes (COL-1, ALP, OPN, and RUNX2) were markedly lower in the co-culture supernatant and Jurkat T cell supernatant groups than those in the normal culture medium group; however, expression levels were significantly increased in the co-culture supernatant group when compared with the Jurkat T cell supernatant group. CONCLUSION:Our findings indicate that GMSCs could promote the osteogenic differentiation of MC3T3-E1 cells by inhibiting the biological activity of activated T cells.

Human gingiva tissue-derived MSC ameliorates immune-mediated bone marrow failure of aplastic anemia via suppression of Th1 and Th17 cells and enhancement of CD4+Foxp3+ regulatory T cells differentiation

Human GMSCs Treat Murine Model with Aplastic Anemia Through Regulating the Balance Between Treg and Th17 Cells

Reduction in Murine Acute GVHD Severity by Human Gingival Tissue-Derived Mesenchymal Stem Cells Via the CD39 Pathways

Human Gingiva-Derived Mesenchymal Stromal Cells Inhibit Graft-Versus-Host Disease Through CD39 and IDO.

Human Gingiva-Derived Mesenchymal Stem Cells Inhibit Xeno-Graft-Versus-Host Disease Via Cd39-Cd73-Adenosine and Ido Signals

Human gingiva-derived mesenchymal stromal cells inhibit graft-versus-host disease through CD39 and IDO (THER5P.844)

Human gingiva-derived mesenchymal stem cells promote osteogenic differentiation through their immunosuppressive function.

Updates on GMSCs treatment for autoimmune diseases.

Human Gingiva-derived Mesenchymal Stem Cells Promote Osteogenic Differentiation via Suppressing T Cell Biological Activity

Human Gingiva-Derived Mesenchymal Stem Cells Ameliorate Streptozoticin-induced T1DM in Mice Via Suppression of T Effector Cells and Up-regulating Treg Subsets

Transplantation of Human Bone Marrow Mesenchymal Stem Cell Ameliorates the Autoimmune Pathogenesis in MRL/lpr Mice

Gingiva-derived Mesenchymal Stem Cells-Mediated Therapeutic Intervention for Experimental Arthritis Through Foxp3+ Tregs (56.7)

B7-H1 Promotes the Functional Effect of Human Gingiva-Derived Mesenchymal Stem Cells on Collagen-Induced Arthritis Murine Model

Use of Gingiva-Derived MSC Ameliorates CIA Via Suppressing Th1 and Th17 and Enhancing Treg Cell Differentiation (P4158)

Bone marrow mesenchymal stem cells for the treatment of immune induced aplastic anemia

A Preclinical Studysystemic Evaluation of Safety on Mesenchymal Stem Cells Derived from Human Gingiva Tissue

Mesenchymal Stem Cells Derived from Human Gingiva Are Capable of Immunomodulatory Functions and Ameliorate Inflammation-Related Tissue Destruction in Experimental Colitis

A preclinical study—systemic evaluation of safety on mesenchymal stem cells derived from human gingiva tissue

Human Gingiva-Derived Mesenchymal Stem Cells Alleviate Inflammatory Bowel Disease via IL-10 Signaling-Dependent Modulation of Immune Cells.

B Lymphocytes Are the Target of Mesenchymal Stem Cells Immunoregulatory Effect in a Murine Graft-versus-Host Disease Model

Single-cell analysis of immune cells on gingiva-derived mesenchymal stem cells in experimental autoimmune uveitis